Form D · Other Investment Fund
3D Bio Therapeutics, a Series of VUVP Fund I, LLC
Salt Lake City, UT · CIK 0001921810
Offering snapshot reported May 2, 2022 · SEC filing
- Reported sold
- $317K Offering amount: $317K
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Apr 26, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 2, 2022 | Initial | $316,600 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-444034
Source: Form D, filed May 2, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Assure Fund Management Ii | Director |
| Jeremy Neilson | Executive |
| Richard Thoms | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
6510 S Millrock Drive Suite 400
Salt Lake City, UT, 84121
Salt Lake City, UT, 84121